NEVVI Medicare utilization intelligence
or

← back

Provider profile

MCINTYRE, KRISTI MD

Medical Oncology · NPI 1912949033 · DALLAS, TX

1
Groups
60
Codes · 2024
73,657
Disclosed services

MCINTYRE, KRISTI is a Medical Oncology in DALLAS, TX, a member of 1 medical group, who billed 60 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

73,657
disclosed services
60
codes billed to Medicare Part B
Prior year · CY2023 75,158 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
J1453 Injection, fosaprepitant, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J9190 Injection, fluorouracil, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
82784 Gammaglobulin (immune system protein) measurement
J9045 Injection, carboplatin, 50 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
83521 Measurement of immunoglobulin light chains
96372 Injection of drug or substance under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
83615 Lactate dehydrogenase (enzyme) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
J7030 Infusion, normal saline solution , 1000 cc
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3490 Unclassified drugs
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82378 Carcinoembryonic antigen (cea) protein level
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
85055 Reticulated (young) platelet measurement
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82232 Beta-2 microglobulin (protein) level
96360 Infusion into a vein for hydration, 31-60 minutes
82607 Cyanocobalamin (vitamin b-12) level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96361 Infusion into a vein for hydration, each additional hour
85046 Red blood count automated, with additional calculations
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
84443 Blood test, thyroid stimulating hormone (tsh)
88184 Flow cytometry technique for dna or cell analysis, first marker

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.